Literature DB >> 19428420

Visual and verbal learning in a genetic metabolic disorder.

Amy M Spilkin1, Angela O Ballantyne, Doris A Trauner.   

Abstract

Visual and verbal learning in a genetic metabolic disorder (cystinosis) were examined in the following three studies. The goal of Study I was to provide a normative database and establish the reliability and validity of a new test of visual learning and memory (Visual Learning and Memory Test; VLMT) that was modeled after a widely used test of verbal learning and memory (California Verbal Learning Test; CVLT). One hundred seventy-two neurologically intact individuals ages 5 years through 50 years were administered the VLMT and the CVLT. Normative data were collected and the results suggested that the VLMT is a reliable and valid new measure of visual learning and memory. The aim of Study II was to examine possible dissociations between verbal and visual learning and memory performances in individuals with cystinosis as well as to assess changes in performance as individuals with the disorder age. Thirty-seven individuals with cystinosis and 37 matched controls were administered a new test of visual learning and memory (Visual Learning and Memory Test; VLMT) and the California Verbal Learning Test (CVLT). Individuals with cystinosis performed at a lower level than controls on almost all indices of visual learning and memory while no differences were found between the groups on the verbal measure. Examination of the results on the VLMT indicated that the visual learning and memory impairment in cystinosis may result from difficulty with processing visual information quickly. Study III aimed to remediate the observed visual learning and memory deficit by implementing an intervention that increased the exposure time for visual stimuli. Fifteen individuals with cystinosis were administered a version of the VLMT in which the stimuli were exposed for 3s rather than 1s. Fifteen matched controls were administered the 1-s version of the VLMT. The results of Study III indicated that by increasing the exposure time for each visual stimulus, individuals with cystinosis were able to perform at the same level as control subjects. This is the first study to demonstrate impaired visual learning and spared verbal learning in individuals with cystinosis. These results may provide the foundation for designing cognitive interventions, may lead to further hypotheses regarding the underlying mechanism of the observed visual learning and memory deficit, and have implications for a greater understanding of gene-behavior relationships.

Entities:  

Mesh:

Year:  2009        PMID: 19428420      PMCID: PMC2700001          DOI: 10.1016/j.neuropsychologia.2009.02.032

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  32 in total

1.  Do subgroups of patients with Alzheimer's disease exhibit asymmetric deficits on memory tests?

Authors:  T Demadura; D C Delis; M Jacobson; D Salmon
Journal:  J Clin Exp Neuropsychol       Date:  2001-04       Impact factor: 2.475

2.  Assessing reproducibility of data obtained with instruments based on continuous measurements.

Authors:  M Bédard; N J Martin; P Krueger; K Brazil
Journal:  Exp Aging Res       Date:  2000 Oct-Dec       Impact factor: 1.645

3.  Nonabsorptive hydrocephalus associated with nephropathic cystinosis.

Authors:  D L Ross; C F Strife; R Towbin; K E Bove
Journal:  Neurology       Date:  1982-12       Impact factor: 9.910

4.  The reliability of a difference between two scores: a re-examination of assumptions.

Authors:  P Levy
Journal:  J Clin Psychol       Date:  1966-07

5.  Subjective health complaints in adolescence--reliability and validity of survey methods.

Authors:  S Haugland; B Wold
Journal:  J Adolesc       Date:  2001-10

6.  A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis.

Authors:  M Town; G Jean; S Cherqui; M Attard; L Forestier; S A Whitmore; D F Callen; O Gribouval; M Broyer; G P Bates; W van't Hoff; C Antignac
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

7.  Factors affecting cognitive functioning of hemiplegic children.

Authors:  S C Levine; P Huttenlocher; M T Banich; E Duda
Journal:  Dev Med Child Neurol       Date:  1987-02       Impact factor: 5.449

8.  Evidence for cerebral involvement in nephropathic cystinosis.

Authors:  J H Ehrich; L Stoeppler; G Offner; J Brodehl
Journal:  Neuropadiatrie       Date:  1979-05

9.  Psychosocial and intellectual development in 12 patients with infantile nephropathic cystinosis.

Authors:  G Wolff; J H Ehrich; G Offner; J Brodehl
Journal:  Acta Paediatr Scand       Date:  1982-11

10.  Cerebral atrophy and nephropathic cystinosis.

Authors:  P Cochat; R Drachman; M F Gagnadoux; D Pariente; M Broyer
Journal:  Arch Dis Child       Date:  1986-04       Impact factor: 3.791

View more
  5 in total

1.  Executive function in nephropathic cystinosis.

Authors:  Angela O Ballantyne; Amy M Spilkin; Doris A Trauner
Journal:  Cogn Behav Neurol       Date:  2013-03       Impact factor: 1.600

2.  Neurological impairment in nephropathic cystinosis: motor coordination deficits.

Authors:  Doris A Trauner; Jennifer Williams; Angela O Ballantyne; Amy M Spilkin; Jennifer Crowhurst; John Hesselink
Journal:  Pediatr Nephrol       Date:  2010-07-22       Impact factor: 3.714

Review 3.  Adult complications of nephropathic cystinosis: a systematic review.

Authors:  Rachel Nora Kasimer; Craig B Langman
Journal:  Pediatr Nephrol       Date:  2020-02-03       Impact factor: 3.714

4.  Neurocognitive functioning in school-aged cystinosis patients.

Authors:  M T P Besouw; G M Hulstijn-Dirkmaat; R E A van der Rijken; E A M Cornelissen; C M van Dael; J Vande Walle; M R Lilien; E N Levtchenko
Journal:  J Inherit Metab Dis       Date:  2010-09-03       Impact factor: 4.982

5.  Assessing the integrity of auditory processing and sensory memory in adults with cystinosis (CTNS gene mutations).

Authors:  Ana A Francisco; Alaina S Berruti; Frederick J Kaskel; John J Foxe; Sophie Molholm
Journal:  Orphanet J Rare Dis       Date:  2021-04-13       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.